These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2385096)

  • 21. Can procalcitonin be useful for medullary thyroid cancer?
    Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L
    Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.
    Dora JM; Canalli MH; Capp C; Puñales MK; Vieira JG; Maia AL
    Thyroid; 2008 Aug; 18(8):895-9. PubMed ID: 18651801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
    Schifter S
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
    Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
    Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma.
    Inaji H; Komoike Y; Motomura K; Higashiyama M; Ohtsuru M; Funai H; Kasugai T; Koyama H
    Oncology; 2000 Aug; 59(2):122-5. PubMed ID: 10971170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
    Laure Giraudet A; Al Ghulzan A; Aupérin A; Leboulleux S; Chehboun A; Troalen F; Dromain C; Lumbroso J; Baudin E; Schlumberger M
    Eur J Endocrinol; 2008 Feb; 158(2):239-46. PubMed ID: 18230832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
    Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
    Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
    Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
    Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
    J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
    Trimboli P; Giovanella L
    Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum calcitonin levels in patients with thyroid disorders.
    Oishi S; Shimada T; Tajiri J; Inoue J; Sato T
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):476-81. PubMed ID: 6516695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of somatostatin as a plasma tumor marker in medullary thyroid carcinoma.
    Grauer A; Schroth J; Ziegler R; Raue F
    Thyroid; 1995 Aug; 5(4):287-91. PubMed ID: 7488870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
    Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
    Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
    Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
    Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
    Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
    Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
    Bethel MA; Patel RA; Thompson VP; Merrill P; Reed SD; Li Y; Ahmadi S; Katona BG; Gustavson SM; Ohman P; Iqbal N; Gagel RF; Hernandez AF; Buse JB; Holman RR;
    Diabetes Care; 2019 Jun; 42(6):1075-1080. PubMed ID: 31010875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of PET-CT scan with somatostatin analogue labelled with gallium-68 (⁶⁸Ga-DOTA-TATE PET-CT) in diagnosing patients with disseminated medullary thyroid carcinoma (MTC).
    Pałyga I; Kowalska A; Gąsior-Perczak D; Tarnawska-Pierścińska M; Słuszniak J; Sygut J; Góźdź S
    Endokrynol Pol; 2010; 61(5):507-11. PubMed ID: 21049467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin gene-related peptide in patients with endocrine tumors.
    Takami H; Shikata J; Kakudo K; Ito K
    J Surg Oncol; 1990 Jan; 43(1):28-32. PubMed ID: 2296192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
    Lim SK; Guéchot J; Vaubourdolle M
    Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.